Alexandre Duvignaud

Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial

Florence Ader, Maude Bouscambert‐Duchamp, Maya Hites et al. · The Lancet Infectious Diseases · 2021 · 338 citations · Full text

Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial

François-Xavier Lescure, Hitoshi Honda, Robert Fowler et al. · The Lancet Respiratory Medicine · 2021 · 246 citations · Full text

Epidemiological and clinical characteristics of patients with monkeypox in the GeoSentinel Network: a cross-sectional study

Kristina M Angelo, Teresa Smith, Daniel Camprubí et al. · The Lancet Infectious Diseases · 2022 · 163 citations · Full text

Lassa fever outcomes and prognostic factors in Nigeria (LASCOPE): a prospective cohort study

Alexandre Duvignaud, Marie Jaspard, Ijeoma Chukwudumebi Etafo et al. · The Lancet Global Health · 2021 · 66 citations · Full text

The Antigen-Presenting Potential of Vγ9Vδ2 T Cells During Plasmodium falciparum Blood-Stage Infection

Jennifer Howard, Séverine Loizon, Christopher J. Tyler et al. · The Journal of Infectious Diseases · 2017 · 39 citations · Full text